• Keros Therapeutics (NASDAQ:KROS) Price Target Lowered to $44.00 at Scotiabank

    来源: Buzz FX / 14 12月 2024 16:06:11   America/Chicago


    Keros Therapeutics (NASDAQ:KROS) Price Target Lowered to $44.00 at Scotiabank Written by MarketBeat December 14, 2024 Share Link copied to clipboard. Keros Therapeutics ( NASDAQ:KROS - Get Free Report ) had its price target decreased by equ
    Read more...
分享